Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care System.
James T KearnsJustin T MatulayWilliam E AndersonTimothy C HetheringtonClaud M GriggJason ZhuKris E GastonStephen B RiggsEarle F BurgessPeter E ClarkPublished in: Urology practice (2021)
Men taking 5-ARIs have higher corrected serum PSA at time of referral to urology. As the unadjusted PSA at referral to urology for PCa risk was similar between 5-ARI users and nonusers, this indicates that the effect of 5-ARI use on serum PSA levels is not routinely accounted for when assessing PCa risk.